References
- Male C, Lechner K, Eichinger S, et al. Clinical significance of lupus anticoagulants in children. J Pediatr 1999; 134: 199–205.
- Brandt JT, Triplett DA, Alving B, Schaner L. Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost 1995; 74: 1185–90.
- Ghosh K, Shetty S, Mohanty D. Detection of unexpected lupus anticoagulant during preparation of normal pooled plasma (NPP) from healthy volunteers. Thromb Haemost 2000; 84: 519–21.
- Kurugol Z, Vardar F, Ozkinay F, Kavakli K, Ozkinay C. Lupus anticoagulant and protein S deficiency in otherwise healthy children with acute varicella infection. Acta Paediatr 2000; 89: 1186–9.
- Berube C, Mitchell L, Silverman E, et al. The relationship of antiphospholipid antibodies to thromboembolic events in paediatric patients with systemic lupus erythematosus: a cross-sectional study. Pediatr Res 1998; 44: 351–6.
- Greaves M. Antiphospholipid antibodies and thrombosis. Lancet 1999; 353: 1348–53.
- Echaniz-Laguna A, Thiriaux A, Ruolt-Olivesi I, Marescaux C, Hirsch E. Lupus anticoagulant induced by the combination of valproate and lamotrigine. Epilepsia 1999; 40: 1661–3.
- Finazzi G, Brancaccio V, Moia M, et al. Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four year prospective study from the Italian Registry. Am J Med 1996; 100: 530–6.